It is also involved in the pathogenesis of over 60% of T-ALL cases.6 Accumulating evidence suggests that controlling the stability of NOTCH1 represents a novel approach to regulate the NOTCH1 signaling pathway and thus is attracting increasingly more attention. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.